Comparison of Basiliximab and Anti-Thymocyte Globulin as Induction Therapy in Pediatric Heart Transplantation: A Survival Analysis.
(2015) In Journal of the American Heart Association 5(1).- Abstract
- Basiliximab and anti-thymocyte globulin are widely used drugs for induction therapy after pediatric heart transplantation. The aim of this study was to determine whether any differences could be observed between basiliximab and anti-thymocyte globulin, with respect to long-term mortality, in a population of pediatric cardiac transplant recipients.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/8593459
- author
- Ansari, David
LU
; Höglund, Peter
LU
; Andersson, Bodil
LU
and Nilsson, Johan LU
- organization
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of the American Heart Association
- volume
- 5
- issue
- 1
- article number
- e002790
- publisher
- Wiley-Blackwell
- external identifiers
-
- pmid:26722127
- wos:000371282800004
- pmid:26722127
- scopus:85017074165
- ISSN
- 2047-9980
- DOI
- 10.1161/JAHA.115.002790
- project
- Pancreatic cancer
- language
- English
- LU publication?
- yes
- id
- 536e53c2-837c-4fde-9e60-3dd0f38dee47 (old id 8593459)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26722127?dopt=Abstract
- http://www.scopus.com/inward/record.url?scp=84997830926&partnerID=8YFLogxK
- date added to LUP
- 2016-04-04 09:28:27
- date last changed
- 2022-03-08 00:47:20
@article{536e53c2-837c-4fde-9e60-3dd0f38dee47, abstract = {{Basiliximab and anti-thymocyte globulin are widely used drugs for induction therapy after pediatric heart transplantation. The aim of this study was to determine whether any differences could be observed between basiliximab and anti-thymocyte globulin, with respect to long-term mortality, in a population of pediatric cardiac transplant recipients.}}, author = {{Ansari, David and Höglund, Peter and Andersson, Bodil and Nilsson, Johan}}, issn = {{2047-9980}}, language = {{eng}}, number = {{1}}, publisher = {{Wiley-Blackwell}}, series = {{Journal of the American Heart Association}}, title = {{Comparison of Basiliximab and Anti-Thymocyte Globulin as Induction Therapy in Pediatric Heart Transplantation: A Survival Analysis.}}, url = {{http://dx.doi.org/10.1161/JAHA.115.002790}}, doi = {{10.1161/JAHA.115.002790}}, volume = {{5}}, year = {{2015}}, }